Developing CAR-T/NK cells that target EphA2 for non-small cell lung cancer treatment
IntroductionChimeric antigen receptor (CAR) immunotherapy has revolutionized anticancer therapy, as it accurately targets cancer cells by recognizing specific antigens expressed in cancer cells. This innovative therapeutic strategy has attracted consid…